Company Update: Pfizer Inc (NYSE:PFE) – Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D

[PR Newswire] – CAMBRIDGE, Mass., and DURHAM, N.C., July 2, 2015 /PRNewswire/ — XRpro Sciences , Inc. today announced its acquisition of assets related to the ion channel biology platform from Pfizer Inc. . . . → Read More: Company Update: Pfizer Inc (NYSE:PFE) – Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D Similar Articles: Company Update: Actavis plc (NYSE:ACT) – Actavis cannot drop old version of Alzheimer’s drug – appeals court Company Update (NYSE:PFE): Pfizer, Lilly to resume late-stage study testing pain drug Company Update (NYSE:PFE): Pfizer, FDA in talks on prescription details for key breast cancer drug